Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28264941 | 0.98 | SMN1; SMN2 (0.50) | SMN1; SMN2CA12CA1CA2CA4 | |
| Bicarbonate SCHEMBL27404233 | 0.89 | CA12 (0.53) | SMN1; SMN2CA12CA1CA2CA7 | |
| SCHEMBL11358465 | 0.88 | CA12 (0.42) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL11123445 | 0.85 | CA1 (0.52) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL25434306 | 0.84 | CA1 (0.61) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL27753904 | 0.84 | CA1 (0.61) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL151213 | 0.84 | CA1 (0.61) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL145464 | 0.84 | ALDH1A1 (0.48) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL5399317 | 0.82 | SMN1; SMN2 (0.48) | SMN1; SMN2CA12CA1CA2CA4 | |
| SCHEMBL14120688 | 0.82 | CA12 (0.37) | SMN1; SMN2CA12CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119999908-A | Novel oil-soluble precursor micelle preparation and production method thereof | 酰莱(合肥)生命科学研发有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-120000585-A | Novel drug-assisted precursor micelle preparation and production method thereof | 酰莱(合肥)生命科学研发有限公司 | 2025-05-16 | — | — | CN | claimed |
| EP-3274377-B1 | CATALYST SYSTEM AND PROCESS FOR THE PRODUCTION OF POLYETHYLENES | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-09-06 | — | — | EP | claimed |
| CN-107278210-B | Catalyst system and process for producing polyethylene | SABIC环球技术有限责任公司 | 2020-12-15 | — | — | CN | claimed |
| US-10472439-B2 | Catalyst system and process for the production of polyethylenes | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-11-12 | — | — | US | claimed |
| CN-109481444-A | A kind of taxol and phthalazines class BTK inhibitor drug combination compositions and its application | 南京先进生物材料与过程装备研究院有限公司 | 2019-03-19 | — | — | CN | claimed |
| CN-109481442-A | A kind of taxol and adjacent phenyl phthalazines ketone BTK inhibitor drug combination compositions and its application | 南京先进生物材料与过程装备研究院有限公司 | 2019-03-19 | — | — | CN | claimed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| CN-109394765-A | A kind of taxol and to phenyl phthalazines ketone BTK inhibitor drug combination compositions and its application | 南京先进生物材料与过程装备研究院有限公司 | 2019-03-01 | — | — | CN | claimed |
| EP-3197924-B1 | A CONTINUOUS PROCESS FOR THE PRODUCTION OF ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2019-01-23 | — | — | EP | claimed |
| CN-1350458-A | Protease inhibitors | SMITHKLINE BEECHAM CORP (US) | 2002-05-22 | — | — | CN | claimed |
| EP-1155001-A1 | ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 2001-11-21 | — | — | EP | claimed |
| WO-2000050406-A1 | ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES | LION BIOSCIENCE AG (DE) | 2000-08-31 | — | — | WO | claimed |
| CN-1255367-A | Compsns. for recovering and promoting skin protective functions and its evaluating method | SHISEIDO CO LTD (JP) | 2000-06-07 | — | — | CN | claimed |
| US-6060453-A | Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose | GREENWICH PHARMACEUTICALS INCORPORATED (US) | 2000-05-09 | — | — | US | claimed |
| EP-0834507-A1 | Substituted diamino-1,3,5-triazine derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1998-04-08 | — | — | EP | claimed |
| EP-0500530-B1 | CATALYST COMPONENT FOR MAKING PRIMARILY ISOTACTIC ELASTOMERIC POLYPROPYLENE OR POLYBUTENE | SHELL OIL CO (US) | 1996-09-11 | — | — | EP | claimed |
| US-4971936-A | COORDINATION CATALYST OF MAGNESIUM ALKOXIDE, TETRAVALENT TITANIUM HALIDE AND VERATROLE | SHELL OIL COMPANY (US) | 1990-11-20 | — | — | US | claimed |
| US-4808497-A | WITH DIETHER SOLVENT | EVEREADY BATTERY COMPANY (US) | 1989-02-28 | — | — | US | claimed |
| US-4272634-A | Process for the production of intermediate oxidation products of toluenes having ether linkages | DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1981-06-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | SMN1; SMN2 4265/4885CA12 299/4885CA1 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.